Related Experiment Video

Updated: Jun 22, 2026

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins
10:24

Two- and Three-Dimensional Live Cell Imaging of DNA Damage Response Proteins

Published on: September 28, 2012

14-3-3sigma and p21 synergize to determine DNA damage response following Chk2 inhibition

Shasha Meng1, Tali Arbit, Selvaraju Veeriah

  • 1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA.

Cell Cycle (Georgetown, Tex.)
|June 9, 2009
PubMed

Insights

The study reveals that inhibiting Chk2 kinase in cells lacking p21 and 14-3-3sigma significantly increases DNA damage sensitivity, leading to apoptosis. This highlights a synergistic role for p21 and 14-3-3sigma in DNA damage response.

Area of Science:

  • Cellular biology
  • Molecular oncology
  • Genetics

Background:

  • DNA damage checkpoints are crucial for preventing cancer and managing cellular responses to genotoxic stress.
  • Chk2 kinase, p21, and 14-3-3sigma are known effectors of the G2 DNA damage checkpoint, but their combined roles are not fully understood.

Purpose of the Study:

  • To investigate the synergistic roles of Chk2, p21, and 14-3-3sigma in the DNA damage response.
  • To determine how the interplay between these proteins affects cellular sensitivity to DNA damage and apoptosis.

Main Methods:

  • Genetic perturbation of Chk2, p21, and 14-3-3sigma genes in human cells.
  • Assessment of cellular sensitivity to DNA damage following gene depletion.
  • Pharmacological inhibition of Chk2 in combination with genetic deficiencies.

Main Results:

  • Depletion of Chk2 significantly increased DNA damage sensitivity in cells lacking both p21 and 14-3-3sigma, but not in cells lacking only one.
  • This heightened sensitivity was attributed to increased apoptosis, not G2 checkpoint defects.
  • Pharmacological Chk2 inhibition mirrored these results, showing increased DNA damage sensitivity in p21(-/-), 14-3-3sigma(-/-) cells.

Conclusions:

  • p21 and 14-3-3sigma synergistically determine sensitivity to DNA damage upon Chk2 inhibition.
  • Chk2 acts as a critical modulator of cell fate (arrest vs. apoptosis) after chemotherapeutic treatment.
  • These findings have significant implications for targeting Chk2 in human cancer therapies.

More Related Videos

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage10:59

Visualizing and Quantifying Endonuclease-Based Site-Specific DNA Damage

Published on: August 21, 2021

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts10:55

Study of the DNA Damage Checkpoint using Xenopus Egg Extracts

Published on: November 5, 2012

Related Concept Videos

DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...